Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer.
Cancer Sci. 2023 Feb;114(2):546-560. doi: 10.1111/cas.15622. Epub 2022 Nov 23.
Cancer Sci. 2023.
PMID: 36285485
Free PMC article.
PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade.
Yoshida H, Nomizo T, Ozasa H, Tsuji T, Funazo T, Yasuda Y, Ajimizu H, Yamazoe M, Kuninaga K, Ogimoto T, Hosoya K, Itotani R, Sakamori Y, Kim YH, Hirai T.
Yoshida H, et al. Among authors: kuninaga k.
Eur J Cancer. 2021 Feb;144:317-325. doi: 10.1016/j.ejca.2020.11.035. Epub 2020 Dec 30.
Eur J Cancer. 2021.
PMID: 33385948
Item in Clipboard
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
Ajimizu H, Ozasa H, Sato S, Funazo T, Sakamori Y, Nomizo T, Kuninaga K, Ogimoto T, Hosoya K, Yamazoe M, Tsuji T, Yoshida H, Itotani R, Ueno K, Kim YH, Muro S, Hirai T.
Ajimizu H, et al. Among authors: kuninaga k.
Sci Rep. 2021 Dec 8;11(1):23677. doi: 10.1038/s41598-021-03139-5.
Sci Rep. 2021.
PMID: 34880386
Free PMC article.
Item in Clipboard
Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
Ajimizu H, Ozasa H, Sato S, Funazo T, Sakamori Y, Nomizo T, Kuninaga K, Ogimoto T, Hosoya K, Yamazoe M, Tsuji T, Yoshida H, Itotani R, Ueno K, Kim YH, Muro S, Hirai T.
Ajimizu H, et al. Among authors: kuninaga k.
Sci Rep. 2023 Feb 6;13(1):2117. doi: 10.1038/s41598-023-29102-0.
Sci Rep. 2023.
PMID: 36747076
Free PMC article.
No abstract available.
Item in Clipboard
CD47 polymorphism for predicting nivolumab benefit in patients with advanced non‑small‑cell lung cancer.
Ogimoto T, Ozasa H, Yoshida H, Nomizo T, Funazo T, Yoshida H, Hashimoto K, Hosoya K, Yamazoe M, Ajimizu H, Tsuji T, Sakamori Y, Kuninaga K, Morita S, Hirai T.
Ogimoto T, et al. Among authors: kuninaga k.
Oncol Lett. 2023 Jul 10;26(2):364. doi: 10.3892/ol.2023.13950. eCollection 2023 Aug.
Oncol Lett. 2023.
PMID: 37545625
Free PMC article.
Item in Clipboard
Cite
Cite